跳至主要内容
临床试验/IRCT2013020112333N1
IRCT2013020112333N1已完成未知

To assess the effect of Helicobacter pylori infection eradication on thrombocytopenia in patients with cirrhosis

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 72 years(—)
性别
All

入选标准

  • Patients with thrombocytopenia due to cirrhosis of the liver;
  • platelet count was less than 85,000 per micro liter; The immunoglubin anti- Helicobacter pylori antibodies were positive.
  • Exclusion criteria at the beginning: History of previous treatment for Helicobacter pylori infection eradication; treatment with proton pump inhibitors or antibiotics in the past four weeks; History of allergy drugs for eradicate of Helicobacter pylori infection.
  • Exclusion criteria during the study: allergy to drugs; Helicobacter pylori infection are not eradicated after treatment.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验